Intra-Cellular Therapies, Inc.

Legal & General Group Plc

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/15/2025

Shares

154,271

Value ($000)

20,351

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/15/2025	20,351	0.0%	154,271	3/31/2025
2024 Q4	2/13/2025	12,458	0.0%	149,161	12/31/2024
2024 Q3	2/28/2025	10,838	0.0%	148,125	9/30/2024
2024 Q2	5/29/2025	9,420	0.0%	137,532	6/30/2024
2024 Q1	5/29/2025	9,826	0.0%	141,991	3/31/2024
2023 Q4	5/29/2025	10,810	0.0%	150,942	12/31/2023
2023 Q3	11/14/2023	7,625	0.0%	146,372	9/30/2023
2023 Q2	8/14/2023	9,127	0.0%	144,139	6/30/2023
2023 Q1	5/15/2023	4,664	0.0%	86,127	3/31/2023
2022 Q4	2/14/2023	4,266	0.0%	80,609	12/31/2022
2022 Q3	11/14/2022	3,770	0.0%	81,029	9/30/2022
2022 Q2	8/22/2022	4,779	0.0%	83,731	6/30/2022
2022 Q1	5/16/2022	4,750	0.0%	77,627	3/31/2022
2021 Q4	2/14/2022	3,466	0.0%	66,224	12/31/2021
2021 Q3	11/15/2021	2,248	0.0%	60,295	9/30/2021
2021 Q2	8/12/2021	1,910	0.0%	46,803	6/30/2021
2021 Q1	5/17/2021	1,588	0.0%	46,774	3/31/2021
2020 Q4	2/12/2021	1,284	0.0%	40,369	12/31/2020
2020 Q3	11/13/2020	1,041	0.0%	40,555	9/30/2020
2020 Q2	8/14/2020	1,075	0.0%	41,877	6/30/2020
2020 Q1	5/14/2020	404	0.0%	26,285	3/31/2020
2019 Q4	2/13/2020	725	0.0%	21,107	12/31/2019